Search

Eight applicants were successful, and were awarded $15,000 each for activities supporting subsequent research grant applications.

Research

There is a strong unmet need to improve systemic therapy in mesothelioma. Chemotherapy with cisplatin and pemetrexed improves survival in malignant pleural mesothelioma, and immune checkpoint inhibitors are an emerging treatment in this disease. We aimed to evaluate the activity of durvalumab, an anti-PD-L1 antibody, given during and after first-line chemotherapy with cisplatin and pemetrexed in patients with advanced malignant pleural mesothelioma.

News & Events

The Deborah Lehmann Research Award in Paediatric Infectious Disease Research is a funding mechanism to support the training and development of early- to mid-career researchers (EMCR) or Higher Degree by Research (HDR) students who are nationals from the Pacific Region working in or outside their hom

News & Events

This article explores how to support a child's physical and mental health during critical developmental periods, known as the first 1,000 days of life.

Developmental Origins of Health and Disease

See the latest ORIGINS news.

News & Events

The ORIGINS Project has been named as a key beneficiary of the Stan Perron Charitable Foundation Research People & Platform round for 2023.

Get in touch with ORIGINS via email, phone or find us at one of our two locations

Determining the associations of sun exposure in early life on the development of non-communicable diseases.

This sub-project aims to fill the gap in knowledge of the effects of climate change on child health and wellbeing in Australia, and to propose data-driven adaptation trials to counter the most serious impacts.

This sub-project aims to fill the gap in knowledge of the effects of climate change on child health and wellbeing in Australia, and to propose data-driven adaptation trials to counter the most serious impacts.